Next Article in Journal
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma
Next Article in Special Issue
Impact of HPV Catch-Up Vaccination on High-Grade Cervical Lesions (CIN2+) Among Women Aged 26–30 in Northern Norway
Previous Article in Journal
Enhanced Humoral and Cellular Immune Responses Elicited by Adenoviral Delivery of SARS-CoV-2 Receptor-Binding Motif Fused to Human Fc
Previous Article in Special Issue
Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types
 
 
Article

Article Versions Notes

Vaccines 2024, 12(11), 1248; https://doi.org/10.3390/vaccines12111248
Action Date Notes Link
article pdf uploaded. 1 November 2024 15:20 CET Version of Record https://www.mdpi.com/2076-393X/12/11/1248/pdf-vor
article xml file uploaded 5 November 2024 12:06 CET Original file -
article xml uploaded. 5 November 2024 12:06 CET Update https://www.mdpi.com/2076-393X/12/11/1248/xml
article pdf uploaded. 5 November 2024 12:06 CET Updated version of record https://www.mdpi.com/2076-393X/12/11/1248/pdf
article supplementary file uploaded. 5 November 2024 12:06 CET - https://www.mdpi.com/2076-393X/12/11/1248#supplementary
article html file updated 5 November 2024 12:11 CET Original file -
article html file updated 28 June 2025 19:11 CEST Update https://www.mdpi.com/2076-393X/12/11/1248/html
Back to TopTop